ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
    5.
    发明申请
    ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES 审中-公开
    吡咯烷衍生物的口服制剂

    公开(公告)号:US20170065556A1

    公开(公告)日:2017-03-09

    申请号:US15104683

    申请日:2014-12-15

    申请人: OBSEVA S.A.

    IPC分类号: A61K31/40 A61K45/06 A61K9/20

    摘要: The present invention relates to solid oral formulations comprising a compound of formula (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one-O-methyloxime, and/or an active metabolite thereof, and the use of said formulations in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea and embryo implantation failure due to uterine contractions. The present invention is furthermore related to processes for their preparation.

    摘要翻译: 本发明涉及包含式(3Z,5S)-5-(羟甲基)-1 - [(2'-甲基-1,1'-联苯-4-基)羰基]吡咯烷-3 - 酮-O-甲基肟和/或其活性代谢物,以及所述制剂在治疗和/或预防由于子宫收缩引起的早产,早产,痛经和胚胎植入失败中的用途。 本发明还涉及其制备方法。